Authors:
Klug, SJ
Wilmotte, R
Santos, C
Almonte, M
Herrero, R
Guerrero, I
Caceres, E
Peixoto-Guimaraes, D
Lenoir, G
Hainaut, P
Walboomers, JMM
Munoz, N
Citation: Sj. Klug et al., TP53 polymorphism, HPV infection, and risk of cervical cancer, CANC EPID B, 10(9), 2001, pp. 1009-1012
Citation: M. Olivier et P. Hainaut, TP53 mutation patterns in breast cancers: searching for clues of environmental carcinogenesis, SEM CANC B, 11(5), 2001, pp. 353-360
Authors:
Sepehr, A
Taniere, P
Martel-Planche, G
Zia'ee, AA
Rastgar-Jazii, F
Yazdanbod, M
Etemad-Moghadam, G
Kamangar, F
Saidi, F
Hainaut, P
Citation: A. Sepehr et al., Distinct pattern of TP53 mutations in squamous cell carcinoma of the esophagus in Iran, ONCOGENE, 20(50), 2001, pp. 7368-7374
Authors:
Maurici, D
Monti, P
Campomenosi, P
North, S
Frebourg, T
Fronza, G
Hainaut, P
Citation: D. Maurici et al., Amifostine (WR2721) restores transcriptional activity of specific p53 mutant proteins in a yeast functional assay, ONCOGENE, 20(27), 2001, pp. 3533-3540
Authors:
Vayssier-Taussat, M
Camilli, T
Aron, Y
Meplan, C
Hainaut, P
Polla, BS
Weksler, B
Citation: M. Vayssier-taussat et al., Effects of tobacco smoke and benzo[a] pyrene on human endothelial cell andmonocyte stress responses, AM J P-HEAR, 280(3), 2001, pp. H1293-H1300
Authors:
Coche, EE
Hamoir, XL
Hammer, FD
Hainaut, P
Goffette, PP
Citation: Ee. Coche et al., Using dual-detector helical CT angiography to detect deep venous thrombosis in patients with suspicion of pulmonary embolism: Diagnostic value and additional findings, AM J ROENTG, 176(4), 2001, pp. 1035-1039
Authors:
Guimaraes, DP
Lu, SH
Snijders, P
Wilmotte, R
Herrero, R
Lenoir, G
Montesano, R
Meijer, CJLM
Walboomers, J
Hainaut, P
Citation: Dp. Guimaraes et al., Absence of association between HPV DNA, TP53 codon 72 polymorphism, and risk of oesophageal cancer in a high-risk area of China, CANCER LETT, 162(2), 2001, pp. 231-235
Citation: P. Hainaut et al., TP53 mutation spectrum in lung cancers and mutagenic signature of components of tobacco smoke: lessons from the IARC TP53 mutation database, MUTAGENESIS, 16(6), 2001, pp. 551-553
Citation: P. Hainaut et Gp. Pfeifer, Patterns of p53 G -> T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke, CARCINOGENE, 22(3), 2001, pp. 367-374
Authors:
DeMarini, DM
Landi, S
Tian, DF
Hanley, NM
Li, XM
Hu, FD
Roop, BC
Mass, MJ
Keohavong, P
Gao, WM
Olivier, M
Hainaut, P
Mumford, JL
Citation: Dm. Demarini et al., Lung tumor KRAS and TP53 mutations in nonsmokers reflect exposure to PAH-rich coal combustion emissions, CANCER RES, 61(18), 2001, pp. 6679-6681
Authors:
Taniere, P
Martel-Planche, G
Saurin, JC
Lombard-Bohas, C
Berger, F
Scoazec, JY
Hainaut, P
Citation: P. Taniere et al., TP53 mutations, amplification of P63 and expression of cell cycle proteinsin squamous cell carcinoma of the oesophagus from a low incidence area in Western Europe, BR J CANC, 85(5), 2001, pp. 721-726
Authors:
Chazotte-Aubert, L
Pluquet, O
Hainaut, P
Ohshima, H
Citation: L. Chazotte-aubert et al., Nitric oxide prevents gamma-radiation-induced cell cycle arrest by impairing p53 function in MCF-7 cells, BIOC BIOP R, 281(3), 2001, pp. 766-771
Authors:
Taniere, P
Martel-Planche, G
Maurici, D
Lombard-Bohas, C
Scoazec, JY
Montesano, R
Berger, F
Hainaut, P
Citation: P. Taniere et al., Molecular and clinical differences between adenocarcinomas of the esophagus and of the gastric cardia, AM J PATH, 158(1), 2001, pp. 33-40
Authors:
Kirk, GD
Camus-Randon, AM
Mendy, M
Goedert, JJ
Merle, P
Trepo, C
Brechot, C
Hainaut, P
Montesano, R
Citation: Gd. Kirk et al., Ser-249 p53 mutations in plasma DNA of patients with hepatocellular carcinoma from the Gambia, J NAT CANC, 92(2), 2000, pp. 148-153
Authors:
North, S
El-Ghissassi, F
Pluquet, O
Verhaegh, G
Hainaut, P
Citation: S. North et al., The cytoprotective aminothiol WR1065 activates p21(waf-1) and down regulates cell cycle progression through a p53-dependent pathway, ONCOGENE, 19(9), 2000, pp. 1206-1214
Citation: C. Meplan et al., Metalloregulation of the tumor suppressor protein p53: zinc mediates the renaturation of p53 after exposure to metal chelators in vitro and in intactcells, ONCOGENE, 19(46), 2000, pp. 5227-5236
Authors:
Cortes, U
Moyret-Lalle, C
Falette, N
Duriez, C
El Ghissassi, F
Barnas, C
Morel, AP
Hainaut, P
Magaud, JP
Puisieux, A
Citation: U. Cortes et al., BTG gene expression in the p53-dependent and -independent cellular response to DNA damage, MOL CARCINO, 27(2), 2000, pp. 57-64
Authors:
Taniere, P
Martel-Planche, G
Puttawibul, P
Casson, A
Montesano, R
Chanvitan, A
Hainaut, P
Citation: P. Taniere et al., TP53 mutations and MDM2 gene amplification in squamous-cell carcinomas of the esophagus in South Thailand, INT J CANC, 88(2), 2000, pp. 223-227
Authors:
Buller, HR
Cariou, R
Gallus, A
Gent, M
Ginsberg, J
Prins, MH
Lensing, A
Levi, M
Nurmohammed, N
Hirsh, J
Roberts, R
ten Cate, JW
Decousus, H
Mismetti, P
Buchmuller, A
Charlet, V
Viallon, A
van der Meer, J
Meinardi, JR
Meijer, K
Piovella, F
Barone, M
Beltrametti, C
Serafini, S
Kraaijenhagen, RA
Koopman, MMW
Jagt, HHT
Muller, MBR
Kooy, MV
Nauta, S
Gallus, AS
Coghlan, D
Rich, C
Prandoni, P
Scudeller, A
Scarano, L
Girolami, A
Baker, R
Tan, E
Cooney, J
Eikelboom, J
Ninet, J
Dolmazon, C
Madoux, MHG
Coppere, B
Nenci, GG
Agnelli, G
Falcinelli, F
Morini, M
d'Angelo, A
Crippa, L
d'Angelo, SV
Chong, B
Chestreman, C
Malvin, J
Eisbacher, M
MacGillavry, MR
Brandjes, DPM
Beaumont, JFM
Olmos, RAV
Turpie, AGG
Johnson, J
Nowacki, B
Anderson, D
Pleasance, S
Mitchell, M
Ockelford, P
Bennett, A
Jones, R
Porteous, F
Weitz, J
Kearon, C
Simonneau, G
Parent, F
Douketis, J
Schnurr, T
Hainaut, P
Petit, B
Jaumotte, C
Huisman, MV
van Poelgeest, MIE
Meinders, AE
van Oostayen, JA
Beer, J
Lugli, A
Pederiva, S
Ginsberg, J
Brill-Edwards, P
Stevens, P
Bassand, JP
Seronde, MF
Kassis, J
Fortin, M
Faivre, R
Petiteau, PY
Verhaeghe, R
Wells, P
Lewandowski, B
Touchie, D
Banga, JD
Hartmann, IJC
Zeguers, VJM
Desjardins, L
Villeneuve, J
Cote, J
Bounameaux, H
Cirafici, P
Demers, C
van der Heul, C
Kruip, M
Citation: Hr. Buller et al., Treatment of proximal deep vein thrombosis with a novel synthetic compound(SR90107A/ORG31540) with pure anti-factor Xa activity - A phase II evaluation, CIRCULATION, 102(22), 2000, pp. 2726-2731